Pharmacometrics Center of Excellence
Learn more Â鶹Porn’s Pharmacometrics Center of Excellence (MWUPCE). Faculty investigators conduct pre-clinical through post-marketing studies.
Â鶹Porn's Pharmacometrics Center of Excellence
The Â鶹Porn Pharmacometrics Center of Excellence (MWUPCE) partners strong faculty knowledge base in computer modeling of drug efficacy and toxicity with wet-lab analytic approaches. Together, the group is highly expert conducting pre-clinical through post-marketing studies. The Center builds on the existing synergies in the University's Core Research Facility.
Mission
The mission of the MWUPCE is to:
- Design innovative strategies that maximize safe and effective pharmacotherapy for patients
- Develop the next generation of translational clinicians and scientists through advanced pharmacometric education.
Research Opportunities for Current Pharmacy Students
We welcome interested students to join in our research. Current College of Pharmacy, Downers Grove (CPDG) students may and access our opportunities via the “CPDG Resources” Canvas site. To review investigators’ options, select “Faculty Research Participation” and then select the link found under “Connect with Faculty."
Meet the Pharmacometrics Center of Excellence Investigators
Dr. Andurkar serves as Professor and Chair of the Department of Pharmaceutical Sciences. He earned his M.S. and Ph.D. in Medicinal Chemistry from Auburn University, Department of Pharmaceutical Sciences. He completed his postdoctoral studies at the University of Houston, Department of Chemistry. Dr. Andurkar has more than 25 years of experience in the design, synthesis, isolation and purification, structural elucidation, drug metabolism, and pharmacological studies of bioactive molecules. His current research interests are in the design, synthesis, and pharmacological evaluation of novel analgesics and antiepileptic agents, as well as the study of novel synthetic organic chemical methodologies, stereoselective synthesis, and evaluating the impact of stereochemistry on biological activity. He serves as scientific advisor to Aagami Inc., and Pharmazz Inc.
Dr. Elizabeth Davydoff earned a Doctor of Pharmacy degree from Â鶹Porn College of Pharmacy in 2026. Following graduation, Dr. Davydoff joined as an Infectious Diseases Pharmacotherapy Fellow at Â鶹Porn to further develop expertise in pharmacometrics and clinical pharmacology. Research interests include pharmacokinetics and pharmacodynamics (PK/PD), population pharmacokinetic modeling, and the application of pharmacometric approaches within infectious diseases. Currently, she is actively engaged in various activities including clinical data pharmacokinetic modeling and simulation of antibiotics. Upon completion of the fellowship, Dr. Davydoff is interested in pursuing a career in the pharmaceutical industry.
Dr. Medha D. Joshi is an Associate Professor in Pharmaceutical Sciences at Â鶹Porn's College of Pharmacy, Glendale Campus. Dr. Joshi has expertise in lipid based drug delivery systems including solid lipid nanoparticles (SLN), micro emulsions, self-emulsifying drug delivery systems (SMEDDs), nanosuspensions, and liposomes etc. targeted drug delivery. Her research program at Midwestern university is focused on application of nanoparticulate targeted delivery a) to neurogenetic peptides for their delivery to the blood brain barrier, and b) reduction of maternal-fetal toxicity of drugs across the placental barrier. She has more than 30 peer-reviewed research articles, two patents, and three book chapters to her credit. She has been a principle investigator and co-investigator on several intramural and extramural grants, including the Alzheimer's Drug Discovery Foundation and NIH AREA grants.
Dr. Rhodes is an Associate Professor and member of the Â鶹Porn Pharmacometrics Center of Excellence. He currently practices as an Infectious Diseases and Antimicrobial Stewardship pharmacist at Northwestern Memorial Hospital in downtown Chicago. Dr. Rhodes's interests include anti-infective pharmacokinetics and pharmacodynamics. His research is primarily focused on clarifying the antimicrobial-exposure-response profiles in pre-clinical and translational models. His research program also seeks to evaluate how contemporary antimicrobial utilization influences resistance and clinical outcomes. He is actively engaged in infectious diseases organizations and serves as a reviewer for multiple peer-reviewed journals and funding organizations.
